Agensys , Inc. Information

Agensys, Inc. is a privately held biotechnology company that is developing a pipeline of therapeutic monoclonal antibodies to treat solid tumor cancers. These antibodies, many of which are fully human, are being generated to a diverse portfolio of proprietary, clinically relevant cancer targets that encompass 14 types of solid tumors. The Company has the capabilities to both develop and manufacture antibody products and, through a partnership with Abgenix, has access to the XenoMouse(R) technologies required to generate fully human antibodies. In parallel to developing certain antibody products, Agensys aims to establish partnerships to develop and commercialize selected antibody products, and to exploit small molecule, vaccine, and diagnostic applications to its proprietary cancer targets. The Company's laboratories, GMP manufacturing facility and offices are located in Santa Monica, California.